11 February 2021
Assura plc
Exercise of Nil Cost Options under PSP
Assura plc ("Assura"), the leading primary care property investor and developer announces that on 9 February 2021, Jayne Cottam exercised her 2017 PSP awards.
The table below shows the number of shares vesting to Mrs Cottam, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares received following the sale and the resultant shareholding of Ms Cottam and her persons closely associated ("PCAs").
|
Number of Shares awarded |
Number of shares sold to satisfy income tax and national insurance liabilities |
Shares retained |
Shareholding of PDMR and PCAs post exercise
|
Jayne Cottam (CFO) |
167,681 |
(78,810) |
88,871 |
266,537 |
The Remuneration Committee of Assura had agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0. 7376 per share.
Following the allotment, Mrs Cottam transferred 88,871 shares to her husband. The total beneficial holding of Ms Cottam and her PCAs remains the same.
The Notification of Dealing Form for the PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jayne Cottam |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CFO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Vesting of share awards under PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||||
e) |
Date of the transaction
|
9 February 2021 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Sale of 7 8,810 shares to satisfy tax and national insurance liabilities.
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
10 February 2021 |
||||||
f) |
Place of the transaction
|
XLON |
||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Transfer of 8 8,871 shares to Mrs C ottam 's h usband .
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
10 February 2021 |
||||||
f) |
Place of the transaction
|
XLON |
- Ends -
For more information, please contact:
Assura plc |
Tel:
01925 420680 |
Finsbury
Gordon Simpson |
Tel:
0207 251 3801 |
Notes to Editors
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72